ENGN insider trading
enGene Therapeutics Inc.
In the past 36 days, 1 insider bought $10K of enGene Therapeutics Inc. stock in 1 open-market purchase. The largest purchase was $10K by William Grossman (Interim Chief Medical Officer) on Sep 22, 2026.
Insider purchases
| Insider | Value | Holdings | Signal | Traded / filed |
|---|---|---|---|---|
William Grossman Interim Chief Medical Officer |
$10K 5,102 sh @ $1.97 |
New position | Low
|
Sep 22, 2026 Filed Sep 24, 2026 |
Insider sales
No open-market sales by insiders in this period.